S. Tavadia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
S. Tavadia has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
C. S. Munro
Department of Dermatology, Southern General Hospital, Glasgow, UK
1 shared publicationC.S. Munro
Department of Dermatology, Southern General Hospital, Glasgow G51 4TF, U.K.
1 shared publicationE. Mortimer
Department of Adult and Continuing Education, Glasgow University, Glasgow, U.K.
1 shared publication- Robert Campbell Tait
Department of Haematology, Royal Infirmary, Glasgow, United Kingdom
1 shared publication T. A. McDonagh
Cardiology, Royal Infirmary, Glasgow, and
1 shared publication
Latest Publications
- 1 January 2002
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 146 (1) , 107-109
Genetic epidemiology of Darier's disease: a population study in the west of Scotland
Summary Background Darier's disease has a world‐wide distribution, but estimates of prevalence have varied. The discovery that the disease is due to mutations in ATP2A2 provides the opportunity to s...
- 1 January 2002
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 146 (1) , 107-109
Genetic epidemiology of Darier's disease: a population study in the west of Scotland
Summary Background Darier's disease has a world‐wide distribution, but estimates of prevalence have varied. The discovery that the disease is due to mutations in ATP2A2 provides the opportunity to s...
- 1 December 2001
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 26 (8) , 696-699
Platelet and cardiac function in Darier's disease
ATP2A2, the gene that is abnormal in Darier's disease, encodes SERCA2, a calcium pump that is expressed in many tissues. The wide expression of SERCA2 might suggest that ATP2A2 mutations would cause a multisystem disease. There is however, no evidence of consistent extracutaneous manifestations of Darier's disease. We have conducted preliminary studies in patients with Darier's disease, in two extracutaneous systems in which SERCA2 is known to be important, in order to investigate whether subtle defects have been overlooked. We found no evidence for altered cardiac function in 10 patients using two-dimensional, colour and Doppler echocardiography. There were no consistent defects in platelet function in 12 patients, using bleeding time and aggregation studies. We conclude that the skin is sensitive to defects in SERCA2 function to which other systems appear robust.
- 1 December 2001
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 26 (8) , 696-699
Platelet and cardiac function in Darier's disease
ATP2A2, the gene that is abnormal in Darier's disease, encodes SERCA2, a calcium pump that is expressed in many tissues. The wide expression of SERCA2 might suggest that ATP2A2 mutations would cause a multisystem disease. There is however, no evidence of consistent extracutaneous manifestations of Darier's disease. We have conducted preliminary studies in patients with Darier's disease, in two extracutaneous systems in which SERCA2 is known to be important, in order to investigate whether subtle defects have been overlooked. We found no evidence for altered cardiac function in 10 patients using two-dimensional, colour and Doppler echocardiography. There were no consistent defects in platelet function in 12 patients, using bleeding time and aggregation studies. We conclude that the skin is sensitive to defects in SERCA2 function to which other systems appear robust.